INTERNATIONAL PATENT: LYCIA THERAPEUTICS, INC. FILES APPLICATION FOR "LYSOSOMAL TARGETING BIFUNCTIONAL MOLECULES FOR DEGRADATION OF MUSCLE-SPECIFIC KINASE AUTOANTIBODIES"

GENEVA, Feb. 18 -- LYCIA THERAPEUTICS, INC. (400 East Jamie Court, Suite 200South San Francisco, California 94080) filed a patent application (PCT/US2024/041579) for "LYSOSOMAL TARGETING BIFUNCTIONAL MOLECULES FOR DEGRADATION OF MUSCLE-SPECIFIC KINASE AUTOANTIBODIES" on Aug 08, 2024. With publication no. WO/2025/035040, the details related to the patent application was published on Feb 13, 2025.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Inventor(s): CHEN, Tao (c/o Lycia Therapeutics, Inc.400 East Jamie Court, Suite 200South San Francisco, California 94080), IWIG, Jeffrey (c/o Lycia Therapeutics, Inc.400 ...